Dextall | $15,000,000 | (Jul 15, 2025)
Duranta | $7,000,000 | (Jul 15, 2025)
Circuit(US) | $4,500,000 | (Jul 15, 2025) Certified by Founder
Lodge
AvenCell
start up
United States
- Cambridge, Massachusetts
- 22/10/2024
- Series B
- $112,000,000
Based on our deep science and focused on patients in need, we develop next generation immunotherapies for hard-to-treat cancers.
- Industry Biotechnology
- Website https://avencell.com/
- LinkedIn https://www.linkedin.com/company/avencell/
ScienceMachine | $3,500,000 | (Jul 15, 2025)
Bastazo | $5,300,000 | (Jul 15, 2025)
Asepha | $4,000,000 | (Jul 15, 2025)
Moonvalley | $84,000,000 | (Jul 15, 2025)
MOTOR Ai | $20,000,000 | (Jul 15, 2025)
RealSense | $50,000,000 | (Jul 15, 2025)
Live Story | $3,154,279 | (Jul 11, 2025)
Spacelift | $51,000,000 | (Jul 11, 2025)
Cerebrium | $8,500,000 | (Jul 11, 2025)